Rani Therapeutics Holdings Inc. Revenue 2020–2025
Rani Therapeutics Holdings Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Rani Therapeutics Holdings Inc. revenue for the quarter ending March 31, 2026 was 1.7 M, a 893.02% increase year-over-year.
- Rani Therapeutics Holdings Inc. revenue for the twelve months ending March 31, 2026 was 1.9 M.
- Rani Therapeutics Holdings Inc. annual revenue for 2025 was 1.6 M, a 58.85% increase from 2024.
- Rani Therapeutics Holdings Inc. annual revenue for 2024 was 1.0 M.
- Rani Therapeutics Holdings Inc. annual revenue for 2023 was 0.
- Rani Therapeutics Holdings Inc. annual revenue for 2022 was 0.
Rani Therapeutics Holdings Inc. (RANI) — Frequently Asked Questions
Rani Therapeutics Holdings Inc. (RANI) is a publicly traded US company. It has a market capitalization of $53,042.675. In fiscal 2025 it reported revenue of $2M and net income of -$30M. Explore RANI's stock price, financial statements, earnings history, margins and key ratios below.
What is Rani Therapeutics Holdings Inc.'s market cap?
Rani Therapeutics Holdings Inc. (RANI) has a market capitalization of $53,042.675.
What is the RANI stock price?
RANI trades at $0.80 (+2.43% on the day).
How much revenue does Rani Therapeutics Holdings Inc. make?
Rani Therapeutics Holdings Inc. reported revenue of $2M in fiscal 2025.
Is RANI profitable?
In fiscal 2025, Rani Therapeutics Holdings Inc. reported net income of -$30M.